Abstract
The human innate immunity factor apolipoprotein L-I (APOL1) protects against infection by several protozoan parasites, including Trypanosoma brucei brucei. Endocytosis and acidification of high-density lipoprotein–associated APOL1 in trypanosome endosomes leads to eventual lysis of the parasite due to increased plasma membrane cation permeability, followed by colloid-osmotic swelling. It was previously shown that recombinant APOL1 inserts into planar lipid bilayers at acidic pH to form pH-gated nonselective cation channels that are opened upon pH neutralization. This corresponds to the pH changes encountered during endocytic recycling, suggesting APOL1 forms a cytotoxic cation channel in the parasite plasma membrane. Currently, the mechanism and domains required for channel formation have yet to be elucidated, although a predicted helix-loop-helix (H-L-H) was suggested to form pores by virtue of its similarity to bacterial pore-forming colicins. Here, we compare recombinant human and baboon APOL1 orthologs, along with interspecies chimeras and individual amino acid substitutions, to identify regions required for channel formation and pH gating in planar lipid bilayers. We found that whereas neutralization of glutamates within the H-L-H may be important for pH-dependent channel formation, there was no evidence of H-L-H involvement in either pH gating or ion selectivity. In contrast, we found two residues in the C-terminal domain, tyrosine 351 and glutamate 355, that influence pH gating properties, as well as a single residue, aspartate 348, that determines both cation selectivity and pH gating. These data point to the predicted transmembrane region closest to the APOL1 C terminus as the pore-lining segment of this novel channel-forming protein.
Keywords: APOL1, pH-gated cation channel, pH-dependent membrane insertion, planar lipid bilayers, cytolysis, innate immunity, Trypanosoma brucei, human African trypanosomiasis (HAT), trypanosome lytic factor (TLF), kidney disease, focal-segmental glomerulosclerosis (FSGS), APOL1-associated nephropathy, kidney, ion channel, electrophysiology, apolipoprotein, lipid bilayer, lipoprotein, high-density lipoprotein (HDL), APOL1-associated nephropathy, glomerulosclerosis, nonselective cation channel
Apolipoprotein L-I (APOL1) is a channel-forming innate immune factor that circulates on serum high-density lipoproteins (1). The most well-studied role of APOL1 is in protection against African trypanosome infection. APOL1, APOA1 (apolipoprotein A-1), Hpr (haptoglobin-related protein), and IgM are components of serum trypanosome lytic factors (TLFs), with APOL1 constituting the cytolytic component (2, 3). TLFs protect against infection by several trypanosome parasites, including Trypanosoma congolense and Trypanosoma brucei (1, 4, 5), as well as more distantly related Leishmania parasites (6). However, globally common human APOL1 variants cannot protect against APOL1-resistant T. brucei gambiense and T. brucei rhodesiense, the parasite species responsible for human African trypanosomiasis. In primates, the APOL1 gene is evolving rapidly, and variants exist with broader trypanolytic potential. For example, baboon APOL1 orthologs kill both human-infective subspecies T. brucei rhodesiense and T. brucei gambiense, whereas a human APOL1 variant termed G2 protects against T. brucei rhodesiense infection (7, 8). A second human APOL1 variant termed G1 was associated with reduced severe disease caused by T. brucei gambiense (9). This protection comes at a cost, however, as both the APOL1 G1 and G2 variants cause kidney disease with an etiology based on podocyte injury (10, 11).
Following endocytic uptake of high-density lipoprotein–associated APOL1 into acidic parasite endosomes, African trypanosomes undergo colloid-osmotic swelling and eventual lysis due to an increased plasma membrane cation permeability, which is proposed to result from APOL1 recycling to the plasma membrane, where it forms nonselective cation channels (12, 13). In agreement with this model, cation channel formation by recombinant human APOL1 requires acidic pH (as in endosomes), whereas channel opening requires subsequent pH neutralization (as in recycling to the plasma membrane) (14, 15). APOL1 G1 and G2 expression in podocytes and immortalized cell lines also causes cytoplasmic swelling, which is proposed to result from dysregulated APOL1 channel activity at the plasma membrane (16, 17).
Despite implications for both trypanosomiasis and kidney disease, the molecular details of channel formation by APOL1 remain poorly understood. APOL1 lacks close homology with any known channel-forming proteins, although analogies are made to bacterial pore-forming toxins. Similar to APOL1, these toxins exist as soluble proteins that undergo a conformational change at acidic pH and associate with lipid bilayers to form membrane pores (18). APOL1 also contains a predicted helix-loop-helix (H-L-H) of putative membrane-spanning helices (residues 177–228), which is analogous to the so-called hydrophobic hairpin of diphtheria toxin translocation domain (DpTx-TD) and pore-forming colicins. The hairpin is buried in the crystal structures of colicin and diphtheria toxins at neutral pH (19, 20), yet can insert into lipid bilayers at acidic pH and is integral to channel formation (21, 22). Indeed, a peptide just encompassing the hairpin of DpTx-TD (helices 8 and 9) forms channels with conductance properties similar to those of the intact DpTx-TD (23).
Based on hairpin homology, and on similarity to the C-terminal domain of pore-forming colicins, it was proposed that residues 60–235 of APOL1 constitute the “pore-forming domain” (24). However, the relevance of the H-L-H to channel formation by APOL1 has not been experimentally tested. Unlike in colicins, there are 170 amino acids C-terminal of the APOL1 H-L-H, including a C-terminal domain (CTD; residues 332-398) that contains a putative transmembrane helix and a leucine zipper domain; the CTD also contains the G1 and G2 amino acid changes responsible for APOL1 variant–associated kidney disease. Truncated APOL1 fragments that lack parts of the CTD cannot form channels and do not kill trypanosomes, suggesting that the CTD may be involved in channel formation (4, 14). However, it remains to be seen whether these deficiencies result simply from misfolding of these protein fragments.
In this study, we exploited a baboon APOL1 ortholog which is different enough from human APOL1 (59% identity) to engender enhanced trypanolytic potential yet similar enough to form functional human-baboon APOL1 chimeras (8). We show that recombinant baboon APOL1 forms conductances in planar lipid bilayers that are less pH-dependent and less cation-selective than those formed by human APOL1. Using interspecies chimeras, as well as single amino acid substitutions, we dissect the contributions of hairpin (H-L-H) and C-terminal domains to channel formation by APOL1. Although our data point to a role of the hairpin in facilitating pH-dependent membrane insertion, we found no evidence for hairpin involvement in selectivity or gating functions. Instead, we demonstrate a central role for the putative transmembrane region of the CTD in these aspects of channel formation.
Results
Differences between the lytic capacities of human and baboon APOL1 have long been established, with baboon APOL1 having the ability to lyse the human-infective subspecies T. brucei rhodesiense and T. brucei gambiense (7, 8). Whereas C-terminal differences account for lysis of T. brucei rhodesiense, the mechanism by which T. brucei gambiense is lysed by baboon APOL1 has yet to be identified. To identify potential differences in channel-forming properties between human and baboon APOL1, recombinant APOL1 (rAPOL1) proteins were first purified from Escherichia coli as described previously (14, 25). Recombinant human APOL1 (HsAPOL1) and recombinant baboon APOL1 (PhAPOL1) were first tested in 24-h trypanolytic assays. As expected, both proteins killed T. brucei brucei 427 in vitro (Fig. S1), whereas PhAPOL1 also killed 427-SRA (T. brucei rhodesiense) and T. brucei gambiense, confirming its enhanced lytic activity (Fig. S2).
Substitution of human-specific glutamate residues into the baboon APOL1 H-L-H increases the pH dependence of channel formation
To assess any differences in channel formation, we compared the ability of HsAPOL1 and PhAPOL1 to form a conductance in the planar lipid bilayers (Fig. 1A). As reported previously, HsAPOL1 can only insert into bilayers to form a conductance when exposed to a cis-acidic buffer of pH <6.0 (Fig. 1B) (14, 15). In contrast, PhAPOL1 began to form a conductance at cis pH 7.2, and the rate of formation was substantially increased when the cis side was acidified slightly to pH 6.6 (Fig. 1B), indicating a relaxed pH dependence. To account for this difference, we focused on an H-L-H motif (residues 177–228), which may be similar to the hydrophobic hairpin of bacterial pore-forming toxins (26). The H-L-H of HsAPOL1 contains two acidic amino acid residues, glutamate 201 and glutamate 213 (Glu-201/Glu-213), which are replaced by the uncharged alanine 187 and glycine 199 (Ala-187/Gly-199) in PhAPOL1 (Fig. 2). We hypothesized that substituting these glutamate residues to match baboon APOL1 (Fig. 2) would result in a gain of function toward channel formation at pH 7.2 (Fig. 3A). However, the ability of HsAPOL1 E201A/E213G to form channels was still dependent on acidification, similar to HsAPOL1 (Fig. 3B). In contrast, when PhAPOL1 residues alanine 187 and glycine 199 were substituted for glutamate to match the human residues (A187E/G199E), there was a loss of conductance formation at neutral pH 7.2 (Fig. 3C), whereas conductance formation at acidic pH was maintained (Fig. 3D). Therefore, nonpolar residues in the baboon APOL1 H-L-H allow for channel formation at neutral pH, whereas the mechanisms by which human APOL1 forms channels in a strictly pH-dependent manner remain unclear.
Interspecies differences in the CTD affect pH gating and selectivity
To investigate potential differences in pH gating between human and baboon APOL1, recombinant proteins were subjected to titrations with KOH and HCl in the planar bilayer system (Fig. 4). As shown previously, the conductance formed by HsAPOL1 is minimal after insertion into the bilayer at pH 5.6 but increases 100–500-fold upon pH neutralization (Fig. 4A). This increase, which is plotted as a sigmoidal titration curve with a pKa of around 7 (Fig. 4C), is due to the opening of pH-gated channels (14). In contrast, PhAPOL1 formed a relatively large conductance at pH 5.6, and this conductance increased in a nonsigmoidal manner by only 3–5-fold after alkalization to pH 9.2 (Fig. 4, B and C). To account for this difference, we returned to the diphtheria toxin-like H-L-H region (Fig. 2). However, HsAPOL1 E201A/E213G had pH gating properties nearly identical to those of HsAPOL1, indicating that these residues do not contribute to channel gating (Fig. S3).
As C-terminal deletions of APOL1 have been shown to lose functional activity, we next asked whether differences between the CTD of baboon and human APOL1 could explain the divergence in pH gating. We previously found that replacing the entire human APOL1 CTD (residues 322–398) with the entire baboon APOL1 CTD (residues 313–388) generated a nonfunctional (nontrypanolytic) chimera in a transgenic mouse system (8), so instead we opted to use four chimeras (C1–C4) in which different portions of the CTD were exchanged between the human and baboon orthologs (Fig. 5A). Whereas pH gating of the C1 chimera (which differs from HsAPOL1 in the leucine zipper domain) was unchanged compared with HsAPOL1, the C2 chimera had altered pH gating with a shift toward the open state at a more acidic pH (Fig. 5B). As the C1 and C2 chimeras differ by only four amino acid residues at the C-terminal end of a predicted transmembrane region, we made a third chimera (C3) containing only these baboon-specific residues (Y351G, Y354C, E355Q, and S356L) in a human APOL1 background (Fig. 5A). As expected, the titration curve was identical to that of the C2 chimera, indicating that some or all of residues 351 and 354–356 are involved in pH gating (Fig. 5B). We then used a fourth chimera (C4; Fig. 5A) to ask whether the human residues could reconstitute pH gating when substituted into baboon APOL1. Indeed, the C4 titration curve was shifted to a midway point between the human and baboon APOL1, suggesting partial reconstitution of pH gating (Fig. 5C).
To identify which of the four human-specific residues contribute to pH gating, we made individual amino acid substitutions in the HsAPOL1 background (Fig. 5A), focusing on the two tyrosines (Tyr-351 and Tyr-354) and the glutamate (Glu-355), as these residues are conceivably proton-titratable within the relevant pH range. The pH gating of HsAPOL1 Y354C was similar to HsAPOL1, whereas the pH gating of APOL1 Y351G and E355Q were significantly altered (Fig. 5D). The Y351G substitution caused an approximately one-unit decrease in pKa, whereas replacing tyrosine with the similarly shaped but untitratable phenylalanine (Y351F) caused no change in the titration curve (Fig. 5D). We conclude that Tyr-351 is not the pH sensor, but that it may influence the microenvironment of a pH-gating residue, affecting its apparent pKa. Conversely, substitution of glutamate 355 for the isosteric but nontitratable glutamine (E355Q) shifted the pKa nearly one unit toward alkalinity, suggesting that protonation of Glu-355 contributes to normal pH gating of HsAPOL1 (Fig. 5D). Interestingly, the effect of Glu-355 on gating was contingent on the presence of tyrosine at position 351, as the C3 chimera (which contains both Y351G and E355Q substitutions)produced a pH titration curve similar to the single Y351G substitution alone (Fig. 5, B and D). These results suggest that the putative CTD transmembrane region is involved in pH gating of the APOL1 channel.
Having identified separate determinants of channel formation/membrane insertion versus pH gating, we next sought to identify the pore-lining region of APOL1. First, we compared the cation versus anion selectivity of human and baboon APOL1 by measuring the reversal potential (Erev) in the presence of an increasing cis:trans KCl gradient (Fig. 6A). If the channel pore is nonselective, then KCl will diffuse down its concentration gradient with no net transfer of charge, resulting in Erev = 0. On the other hand, if the channel pore is ideally selective for K+ over Cl−, then a cis negative voltage equal to the Nernst potential must be applied to prevent the net movement of charge (see “Materials and methods”). In agreement with previously published results, HsAPOL1 was ideally cation-selective at pH 7.2 (Fig. 6B). Interestingly, we found that PhAPOL1 was not ideally cation-selective at this pH, indicating potential inter-ortholog differences in the pore-lining region (Fig. 6B). To identify molecular determinants of this difference, we tested the selectivity of the previously purified chimeras and point substitutions (Figs. 2 and 5A). Amino acid changes in the H-L-H, either HsAPOL1 E201A/E213G or PhAPOL1 A187E/G199E, had no effect on selectivity (Fig. 6B), and the C-terminal chimeras C1 and C2 were still ideally cation-selective (Fig. 6C). However, the inverse chimera on the baboon APOL1 backbone (C4) showed a shift toward ideal cation selectivity (Fig. 6C), suggesting that the putative CTD transmembrane region influences cation selectivity of the channel.
CTD residue Asp-348 governs selectivity and pH gating of the APOL1 channel
Upon inspection of the putative CTD transmembrane (residues 335–356), we identified two acidic residues, Asp-337 and Asp-348, that could attract cations to the pore and repel anions when in the unprotonated/negatively charged state at neutral pH (Fig. 5A). If so, we reasoned that the permeability ratio of cations to anions would decrease with decreasing pH (as negatively charged side chains become protonated and neutralized). Indeed, when HsAPOL1 was tested in planar lipid bilayers, there was a loss in relative cation permeability as the cis chamber was titrated from pH 7.2 to pH 5.6 and a further loss when the pH was dropped to 5.4 (Fig. 7A). Under the reverse condition of cis pH 7.2, trans pH 5.6, APOL1 maintained its ideal cation selectivity (Fig. 7A). These results implicate Asp-337 and Asp-348 as possible determinants of APOL1 selectivity.
To test this possibility directly, we made individual substitutions of Asp-337 and Asp-348 for the isosteric but uncharged asparagine. The recombinant proteins were then subjected to in vitro trypanolytic assays and incorporated into planar lipid bilayers. APOL1 D337N retained lytic activity similar to that of HsAPOL1 (Fig. S4A), and there was no significant effect of the D337N substitution on channel formation or pH gating in the planar lipid bilayer system (Fig. 7B). Conversely, APOL1 D348N was unable to lyse T. brucei brucei 427 at concentrations nearly 8-fold higher than the LD50 of HsAPOL1 (Fig. S4A). In addition, we found that although APOL1 D348N could insert into lipid bilayers to form a minor conductance at acidic pH, there was little conductance increase (∼5-fold) upon pH neutralization when compared directly with HsAPOL1 in the same lipid bilayer (Fig. 7C). Thus, it is feasible that Asp-348 acts as a second pH-gating residue along with the Glu-355 residue identified earlier (Fig. 5, A and D). To test this possibility, we generated an APOL1 mutant containing both D348N and E355Q substitutions. The double substitution eliminated any appreciable conductance increase upon pH neutralization, suggesting that pH gating depends on protonation of both Glu-355 and Asp-348 residues (Fig. S5B).
Finally, we investigated the effect of D337N and D348N substitutions on cation selectivity. Whereas APOL1 D337N remained ideally cation-selective, the D348N substitution resulted in reduced cation selectivity at pH 7.2 (Fig. 7D), resembling HsAPOL1 at pH 5.4 (Fig. 7A). This result indicates that protonation and accompanying charge neutralization of Asp-348 at acidic pH (when it resembles asparagine) reduces the cation permeability of the APOL1 channel. To test the extent of this influence, we replaced Asp-348 with histidine, which is typically uncharged at neutral pH but becomes positively charged at acidic pH. Like APOL1 D348N, APOL1 D348H was unable to lyse African trypanosomes in vitro (Fig. S4A). Remarkably, the D348H substitution resulted in almost complete loss of ion selectivity in planar lipid bilayers at pH 7.4, whereas at pH 6.1, the conductance became strongly anion-selective (Fig. 7E). Taken together, these results suggest that the pH-dependent charge status of residue 348 dictates both selectivity and pH gating functions of the APOL1 channel.
Discussion
It was previously shown that human APOL1 forms pH-gated channels in planar lipid bilayers and kills African trypanosomes via colloid-osmotic lysis (1, 12, 14). In this paper, we use human-baboon APOL1 chimeras and single-amino acid substitutions to identify key residues and domains affecting channel formation, pH gating, and selectivity. Most significantly, a single residue, aspartate 348, was found to govern pH-dependent channel selectivity and gating functions. Our data indicate that the pore-lining region is constituted, at least in part, by the final predicted transmembrane region (residues 335–356), which is located in the C-terminal domain.
To better discern the mechanism of channel formation by APOL1, we first sought to characterize the channel-forming properties of baboon APOL1, which has increased trypanolytic capabilities compared with its human ortholog (7, 27). Unlike HsAPOL1, PhAPOL1 formed channels in planar lipid bilayers at pH 7.2 (Fig. 1B). This was supported by trypanolytic assay results wherein 10 mm ammonium chloride (which neutralizes acidic endosomes/lysosomes) was able to completely block lysis by HsAPOL1, but not PhAPOL1 (Fig. S1). Furthermore, PhAPOL1 was able to form a relatively large conductance at pH 5.6, which was increased only 2–3-fold upon subsequent neutralization to pH 7.2 (Fig. 4, compare A with C). These gain-of-function properties could help to explain how recombinant baboon APOL1 is able to lyse the human-infective parasite T. brucei gambiense (28) (Fig. S2).
Having defined key differences in channel formation, gating, and ion selectivity between full-length human and baboon APOL1 orthologs, we then focused on the predicted H-L-H (residues 177–228) as a potential pore-lining region (Fig. 2), due to similarity with the hydrophobic hairpin/H-L-H of the pore-forming colicins and diphtheria toxin (29, 30). However, we were unsuccessful in modulating the ion selectivity of either human or baboon APOL1 by exchanging charged glutamate residues of the H-L-H between human and baboon APOL1 backgrounds (Fig. 6B). This is in contrast to diphtheria toxin, wherein substitution of H-L-H glutamates for uncharged glutamines affected single-channel conductance or both selectivity and conductance (pore-forming colicins lack charged residues within the H-L-H) (26). Interestingly, H-L-H substitutions A187E/G199E in the PhAPOL1 background did prevent channel formation at neutral pH, suggesting that negatively charged H-L-H residues must be protonated prior to membrane insertion (Fig. 3, C and D). The H-L-H may therefore serve as a membrane anchor, allowing for pH-dependent membrane insertion, with the trans pH 7.2 “trapping” one or more of the glutamates on the trans side (31) (Fig. 3A). However, the reverse substitution in the human APOL1 background (E201A/E213G) does not allow channel formation at neutral pH (Fig. 3B), indicating that another region works in conjunction with the H-L-H for pH-dependent channel formation to occur.
Unlike the channel-forming domains of bacterial pore-forming toxins, APOL1 contains some 170 amino acids C-terminal to the H-L-H (32). This includes a C-terminal putative leucine zipper domain, which was previously identified as the binding site for the serum resistance–associated protein (SRA) of T. brucei rhodesiense (residues 365–398; Fig. 5A). Considering the baboon APOL1 leucine zipper domain has a pI of ∼8.8, compared with ∼4.8 for humans, it is feasible that charge neutralization of this region is also necessary for channel formation (8). Additionally, truncation of the C-terminal leucine zipper domain by 10 or more amino acids abolished trypanolytic activity and was associated with loss of channel-forming ability (4, 14, 33). We therefore refocused on the APOL1 CTD in our search for the prospective pore-lining region (Fig. 5A). Using C-terminal chimeras of human and baboon APOL1, we traced differences in pH gating (Fig. 5) and ion selectivity (Fig. 6) to the putative transmembrane region (human APOL1 residues 335–356) of the CTD, which we now postulate to be a pore-lining α-helix (Fig. 8). This region contains two negatively charged aspartate residues, one of which, aspartate 348 (conserved in human and baboon APOL1), was crucially important to the pH-dependent conductance of cations through the channel. The D348N substitution was associated with reduced overall conductance compared with HsAPOL1 (Fig. 7C) as well as decreased cation selectivity at neutral pH (Fig. 7D), similar to HsAPOL1 at pH 5.4 (Fig. 7A). Substitution for histidine (D348H) reduced cation selectivity still further at neutral pH and actually reversed selectivity from cations to anions at acidic pH (Fig. 7E). In contrast, substitution of a second aspartate (D337N) within the same putative transmembrane region had no effect on either the pH-dependent conductance properties (Fig. 7B) or charge selectivity (Fig. 7D). Together, these results suggest that cation selectivity of the APOL1 channel is electrostatic in nature and dependent to a large extent on the protonation status of a single residue, aspartate 348.
Within the C-terminal domain, we also identified two residues, Tyr-351 and Glu-355, that are involved in pH gating (Fig. 5). Whereas Glu-355 may be directly involved in pH sensing, our data indicate that a bulky hydrophobic residue at position 351 impacts the apparent pKa of a nearby pH sensor, which is not Glu-355. The most promising candidate is Asp-348, as the D348N substitution was associated with minimal channel opening after neutralization (Fig. 7C). Thus, the protonation status of Asp-348 likely governs both pH gating and cation selectivity of the APOL1 channel, with Glu-355 having an additional role in pH sensing. In support of this notion, channel opening was all but eliminated by the double substitution D348N/E355Q (Fig. S5B).
Although we have not directly addressed the number of transmembrane domains of the APOL1 channel, it is currently predicted that APOL1 transverses the membrane three times, with aspartate-348 part of the third transmembrane domain (7). However, if we accept that the H-L-H of APOL1 contains the first two transmembrane domains (19, 21), then a three-transmembrane model would result in one of the pH-sensing residues, Glu-355, being located on the trans side of the membrane and therefore unable to respond to changes in cis pH (Fig. S6A). However, gating of APOL1 E355Q shows diminished dependence on cis pH compared with HsAPOL1, indicating that Glu-355 is located on the cis side of the bilayer (Fig. S6, B and C). At least two alternative possibilities must therefore be considered: 1) Asp-348 is part of a pore loop, and not an actual transmembrane domain, or 2) there is an as yet unidentified transmembrane domain that exists between residues 228 and 335 (i.e. within the previously named “membrane-addressing domain” (24)) such that Glu-355 is oriented on the cis side of a fourth transmembrane domain (Fig. 8, A and B). In support of this idea, TMpred-4 software identified a weak transmembrane region spanning residues 257–276 (Fig. S7), which becomes stronger when negatively charged residues are replaced with their uncharged carboximide derivatives to simulate the low pH (protonated) state (Fig. S8). Furthermore, a naturally occurring substitution (N264K) in this region significantly diminished its predicted transmembrane propensity and abrogated both trypanolytic and channel-forming activity (Figs. S7 and S9). The presence of a pore loop also seems unlikely, as these are typically flanked by transmembrane helices (35), which are not apparent in the case of APOL1.
Overall, our data suggest a relatively narrow APOL1 pore with Asp-348 located near the center of its longitudinal axis, such that in the closed channel state, Asp-348 is shielded from the bulk cis solution by a constriction of the pore provided by Tyr-351. We propose a leucine zipper dimer model, wherein the deprotonation of Glu-355 at neutral cis pH helps to overcome the constriction of the pore imposed by Tyr-351 residues of adjacent subunits, perhaps due to intersubunit electrostatic repulsion between Glu-355 residues pushing the tyrosines apart (Fig. 8C). This would increase the exposure of Asp-348 to the bulk cis solution and allow for its deprotonation at neutral cis pH, which would in turn allow for the conductance of cations through the channel, in agreement with the sigmoidal titration curves we observed (Figs. 5 and 8C). In support of this, the Y351G mutation removes the steric block applied by Tyr-351 and shifts the titration curve toward acidic pH, because Asp-348 can now more readily access the cis milieu. Conversely, APOL1 E355Q is unable to remove the steric block by deprotonation of Glu-355, and the curve is shifted toward basic pH, due to the limited access of Asp-348 to the bulk cis solution (Fig. 5D). It should be noted that we were unable to replicate the nonsigmoidal pH dependence of baboon APOL1 with any of the chimeras tested, suggesting that additional regulatory sequences may exist within the unexamined N-terminal half of the pore-lining region.
Our findings agree with previously published reports that APOL1 forms a cation-selective conductance after the pH is shifted from first acidic (pH 5.5–6.0) to neutral pH, in both planar lipid bilayers and lipid vesicles (14, 15). However, there are conflicting data on the selectivity of APOL1 at acidic pH. Utilizing TLF purified from human plasma, Molina-Portela et al. (13) found APOL1 to be nonideally cation-selective in planar lipid bilayers, with a pK+/pCl− of 4.7 at cis pH 5.5, trans pH 7.4. This falls between our estimates of pK+/pCl− ∼2.9 at cis pH 5.4 and ∼5.1 at cis pH 5.6 (Fig. 7A), in agreement with our assessment that APOL1 becomes less selective for cations as aspartate 348 becomes more protonated/neutralized. However, when full-length recombinant APOL1 was inserted into the extravesicular side of phospholipid vesicles at either asymmetric pH (pH 5.5 extravesicular, pH 8.0 intravesicular) or symmetric pH (pH 5.0 extra- and intravesicular), a large, anion-selective conductance was observed when paired with the cation carrier valinomycin (15). Conversely, in planar lipid bilayers, we have only ever observed a relatively small HsAPOL1-induced conductance at asymmetric pH (pH 5.4 cis and pH 7.4 trans), which was determined in this paper to be nonideally cation-selective (Fig. 7A). We conclude that the anion-selective conductance observed by Bruno et al. (15) is likely due to a separate molecular species (such as a non-channel-forming APOL1 conformation), which may manifest due to the very low-ionic strength conditions used or the membrane curvature in the vesicle system (34). However, the authors also observed a small acid-dependent cation conductance when rAPOL1 was paired with the chloride carrier Cl1, specifically when rAPOL1 was added under pH 5.0 extravesicular and pH 8.0 intravesicular conditions. This cation conductance was also amplified by neutralization of extravesicular pH, similar to our observations using planar lipid bilayers. Therefore, it appears that formation of the APOL1 cation channel state depends on a neutral trans/intravesicular pH to “trap” acidic APOL1 residues in a charged state.
The findings in this paper also shed light on the mechanism of trypanosome lysis by APOL1. It has long been understood that cytoplasmic swelling follows cation flux across the plasma membrane when trypanosomes are treated with human serum (12). This effect can be delayed by adding sucrose to the growth media to prevent osmotic swelling or if either Na+ ions or Cl− ions are replaced with the larger ions tetramethylammonium+ or gluconate−, respectively (12, 13). These data support a model in which APOL1 forms cell-surface channels after insertion into the endosome membrane (13). Another group has suggested that APOL1 forms pores in the lysosomal membrane, causing lysosomal swelling and eventual parasite death, or that lysis results from mitochondrial membrane disruption due to the formation of nonselective APOL1 megapores in the outer mitochondrial membrane (24, 36). With regard to the latter, we have never observed anything other than the cation-selective, pH-gated properties described herein. Although APOL1 could possibly collaborate with other trypanosome proteins to form a megapore, it would remain to be explained how the loss-of-function D348N and D348H substitutions might affect this process. Rather, we show that APOL1 D348N and D348H substitutions dramatically reduce APOL1 cation channel conductance (Fig. 7 (C–E) and Fig. S5) while eliminating trypanosome killing (Fig. S4). These data also suggest that the residual conductance observed at acidic pH could not explain trypanosome lysis if it manifested in the lysosomal membrane, as both HsAPOL1 and the loss-of-function D348N/H mutants were competent in this regard (Fig. 7C and Fig. S5). Instead, our data further support the notion that endocytic recycling of APOL1 drives lysis of trypanosomes via the pH-dependent opening of APOL1 cation channels in the parasite plasma membrane. Intriguingly, Giovinazzo et al. (17) recently reported that induction of human cell swelling and lysis by APOL1 renal risk variants depends on a nonselective cation influx at the plasma membrane. We anticipate that the mutants described herein will allow us to further investigate the precise role of APOL1 cation channels in trypanolysis, as well as the potential role of APOL1 cation channel formation in the development of cytotoxicity caused by APOL1 renal risk variants.
Materials and methods
PCR mutagenesis and bacterial production of APOL1
We used as our human APOL1 coding sequence (accession number O14791) the most globally prevalent variant (Lys-150, Ile-228, Lys-255 (37)). An N-terminally His6-tagged version of the mature protein, termed as “HsAPOL1” (residues 28–398), was produced by E. coli from the pNIC-28 expression vector (Addgene) as described previously (14, 25). The corresponding baboon APOL1 coding sequence was previously obtained from Papio hamadryas liver (accession number C9WF17 (8)). The mature protein fragment encoding residues 28–388, termed in this paper as “PhAPOL1”, was similarly produced in E. coli with an N-terminal His tag. Nucleotide sequences encoding APOL1 chimeras 1 and 2 were generated previously and inserted into pNIC28 (8). All other substitutions and chimeras were generated by site-directed mutagenesis, under standard conditions (QuikChange II, Agilent Technologies).
APOL1 protein purification
Recombinant His-tagged APOL1 was produced as insoluble inclusion bodies in E. coli (Bl21-DE3 RIPL, Agilent Technologies) and purified as described previously (14, 25), except for the following modifications. Bacterial pellets were first resuspended and then sonicated in lysis buffer (50 mm Tris-HCl, pH 8.0, 1 mm EDTA), and then 100 μg/ml lysozyme, 5 μg/ml DNase I, and 5 μg/ml RNase I were added. The suspension was stirred for 30 min at room temperature (RT), and then 0.5% (w/v) sodium deoxycholate (made fresh) and 0.5% Triton X-100 (Surfact-AMPS, Pierce) were added, together with 3.5 mm MgCl2 and 2.5 mm CaCl2 to stimulate nuclease activity. After an additional 30 min of stirring at RT, the suspension was sedimented at 26,000 × g, resuspended in 1% Triton X-100 and 100 mm NaCl in lysis buffer, and then stirred for an additional 30 min at RT. After further washes with 100 mm NaCl in lysis buffer, followed by 20% (v/v) lysis buffer in water, the pellet was then solubilized in 2% zwittergent 3-14 (Calbiochem) and purified by nickel chelate chromatography, followed by size-exclusion chromatography as detailed previously. The purified protein still dissolved in size-exclusion chromatography buffer (50 mm Tris-HCl, pH 8.5, 150 mm NaCl, 0.05% dodecyl maltoside) was flash-frozen on dry ice in small aliquots (<0.1 ml).
24-h trypanolytic killing assay
Human serum–sensitive Lister-427–derived T. brucei 427 were cultured in HMI-9 medium (38). Recombinant APOL1 proteins were serially diluted in HMI-9 medium and then combined with 5 × 105 trypanosomes/ml in triplicate wells of a 96-well plate. The plate was incubated for 20 h at 37 °C (5% CO2), and then viability was determined using a 4-h alamarBlue assay (Invitrogen) as described by the manufacturer. Data were analyzed and graphed using Prism 8 software by GraphPad.
Planar lipid bilayers
Soybean phospholipids (asolectin/lecithin type IIS from Sigma) were prepared by the method of Kagawa and Racker (39). Planar lipid bilayers were formed essentially as described by Qiu et al. (40). Briefly, asolectin and cholesterol (Sigma, C8667) were dissolved together in pentane at concentrations of 1.5 and 0.5% (w/v), respectively. Bilayers were formed across a ∼100-μm hole in a Teflon partition separating two 1-ml chambers. The partition was pretreated with 3% (v/v) squalene (Sigma, S3626) in petroleum ether. Unless otherwise stated, chamber buffer (5 mm potassium succinate, 5 mm K-HEPES, 150 mm KCl, 5 mm CaCl2, and 0.5 mm EDTA, pH 7.2) was then added to each side, and 20 μl of the asolectin/cholesterol solution was layered on top. Salt bridges made of 3% (w/v) agar and 3 m KCl connected Ag/AgCl electrodes to the solutions in both compartments. The solvent was allowed to evaporate, and then lipid bilayers were formed by alternately raising the level of each solution above the hole using syringes connected to each side. Lipid bilayer formation was detected as a rapid increase in system capacitance upon raising the solution above the hole. If not observed, the solution levels on each side were alternately lowered and then raised again until a stable bilayer was formed. Each chamber could be stirred by magnetic fleas, allowing for pH adjustment with the addition of precalibrated volumes of 0.5 m HCl or KOH. The cis chamber was defined as the side to which protein was added. The voltage was maintained by the BC-535C bilayer clamp (Warner Instruments), and the current output was passed through a low-pass eight-pole Bessel filter (Warner Instruments) at 10 Hz. The voltage of the cis side is reported relative to the trans. Recording of the current and voltage was done with IGOR NIDAQ Tools MX 1.0 and IGOR software (WaveMetrics) using the National Instruments analog-to-digital converter (NI USB-6211).
Cation versus anion selectivity was assessed by measuring the reversal potential of the macroscopic conductance in the presence of varying cis:trans KCl gradients. The reversal potential (Erev) was determined by adjusting the voltage until the current read zero. The value of Erev in the case of ideal potassium selectivity was calculated using the Nernst potential,
(Eq. 1) |
where αK+ is the potassium+ activity (taken as equal to the KCl activity) (41).
Data availability
All relevant data are contained in the article or in the supporting information.
Supplementary Material
Acknowledgments
We thank Dr. Alan Finkelstein (Albert Einstein College of Medicine, New York, NY, USA) for generously providing equipment and advice and Dr. Joe Giovinazzo (University of Colorado, Denver, CO, USA) for helpful discussions. We also thank Dr. Jyoti Pant (Hunter College, CUNY) and Alisha Racho-Jansen, MA (Hunter College, CUNY) for constructive critiques of the manuscript.
This article contains supporting information.
Author contributions—C. S., J. R., and R. T. conceptualization; C. S., J. V., P. L., N. T., G. L., and R. T. resources; C. S., J. V., P. L., and R. T. formal analysis; C. S., J. R., and R. T. supervision; C. S., J. V., P. L., N. T., G. L., and R. T. investigation; C. S., J. R. and R. T.; C. S. and R. T. methodology; C. S. and R. T. writing-original draft; J. R. funding acquisition; J. R. project administration; J. R and R. T. writing-review and editing.
Funding and additional information—This work was supported by National Science Foundation Grant IOS-1249166 (to J. R.).
Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.
- APOL1
- apolipoprotein L-I
- TLF
- trypanosome lytic factor
- H-L-H
- helix-loop-helix
- DpTx-TD
- diphtheria toxin translocation domain
- CTD
- C-terminal domain
- SRA
- serum resistance–associated protein
- RT
- room temperature
- CHES
- 2-(cyclohexylamino)ethanesulfonic acid.
References
- 1. Vanhamme L., Paturiaux-Hanocq F., Poelvoorde P., Nolan D. P., Lins L., Van Den Abbeele J., Pays A., Tebabi P., Van Xong H., Jacquet A., Moguilevsky N., Dieu M., Kane J. P., De Baetselier P., Brasseur R., et al. (2003) Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422, 83–87 10.1038/nature01461 [DOI] [PubMed] [Google Scholar]
- 2. Raper J., Fung R., Ghiso J., Nussenzweig V., and Tomlinson S. (1999) Characterization of a novel trypanosome lytic factor from human serum. Infect. Immun. 67, 1910–1916 10.1128/.67.4.1910-1916.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Verdi J., Zipkin R., Hillman E., Gertsch R. A., Pangburn S. J., Thomson R., Papavasiliou N., Sternberg J., and Raper J. (2020) Inducible germline IgMs bridge trypanosome lytic factor assembly and parasite recognition. Cell Host Microbe 28, 79–88.e4 10.1016/j.chom.2020.04.012 [DOI] [PubMed] [Google Scholar]
- 4. Molina-Portela M. P., Samanovic M., and Raper J. (2008) Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model. J. Exp. Med. 205, 1721–1728 10.1084/jem.20071463 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Wheeler R. J. (2017) Use of chiral cell shape to ensure highly directional swimming in trypanosomes. PLoS Comput. Biol. 13, e1005353 10.1371/journal.pcbi.1005353 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Samanovic M., Molina-Portela M. P., Chessler A.-D. C., Burleigh B. A., and Raper J. (2009) Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection. PLoS Pathog. 5, e1000276 10.1371/journal.ppat.1000276 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Thomson R., Genovese G., Canon C., Kovacsics D., Higgins M. K., Carrington M., Winkler C. A., Kopp J., Rotimi C., Adeyemo A., Doumatey A., Ayodo G., Alper S. L., Pollak M. R., Friedman D. J., et al. (2014) Evolution of the primate trypanolytic factor APOL1. Proc. Natl. Acad. Sci. U. S. A. 111, E2130–E2139 10.1073/pnas.1400699111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Thomson R., Molina-Portela P., Mott H., Carrington M., and Raper J. (2009) Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes. Proc. Natl. Acad. Sci. U. S. A. 106, 19509–19514 10.1073/pnas.0905669106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Cooper A., Ilboudo H., Alibu V. P., Ravel S., Enyaru J., Weir W., Noyes H., Capewell P., Camara M., Milet J., Jamonneau V., Camara O., Matovu E., Bucheton B., MacLeod A., et al. (2017) APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis. Elife 6, e25461 10.7554/eLife.25461 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Friedman D. J., and Pollak M. R. (2016) Apolipoprotein L1 and kidney disease in African Americans. Trends Endocrinol. Metab. 27, 204–215 10.1016/j.tem.2016.02.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Genovese G., Friedman D. J., Ross M. D., Lecordier L., Uzureau P., Freedman B. I., Bowden D. W., Langefeld C. D., Oleksyk T. K., Uscinski Knob A. L., Bernhardy A. J., Hicks P. J., Nelson G. W., Vanhollebeke B., Winkler C. A., et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 10.1126/science.1193032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Rifkin M. R. (1984) Trypanosoma brucei: biochemical and morphological studies of cytotoxicity caused by normal human serum. Exp. Parasitol. 58, 81–93 10.1016/0014-4894(84)90023-7 [DOI] [PubMed] [Google Scholar]
- 13. Molina-Portela M. D P., Lugli E. B., Recio-Pinto E., and Raper J. (2005) Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes. Mol. Biochem. Parasitol. 144, 218–226 10.1016/j.molbiopara.2005.08.018 [DOI] [PubMed] [Google Scholar]
- 14. Thomson R., and Finkelstein A. (2015) Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis. Proc. Natl. Acad. Sci. U. S. A. 112, 2894–2899 10.1073/pnas.1421953112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Bruno J., Pozzi N., Oliva J., and Edwards J. C. (2017) Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles. J. Biol. Chem. 292, 18344–18353 10.1074/jbc.M117.813444 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Olabisi O. A., Zhang J.-Y., VerPlank L., Zahler N., DiBartolo S., Heneghan J. F., Schlöndorff J. S., Suh J. H., Yan P., Alper S. L., Friedman D. J., and Pollak M. R. (2016) APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc. Natl. Acad. Sci. U. S. A. 113, 830–837 10.1073/pnas.1522913113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Giovinazzo J. A., Thomson R. P., Khalizova N., Zager P. J., Malani N., Rodriguez-Boulan E., Raper J., and Schreiner R. (2020) Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity. Elife 9, e51185 10.7554/eLife.51185 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Finkelstein A. (1990) Channels formed in phospholipid bilayer membranes by diphtheria, tetanus, botulinum and anthrax toxin. J. Physiol. (Paris) 84, 188–190 [PubMed] [Google Scholar]
- 19. Choe S., Bennett M. J., Fujii G., Curmi P. M., Kantardjieff K. A., Collier R. J., and Eisenberg D. (1992) The crystal structure of diphtheria toxin. Nature 357, 216–222 10.1038/357216a0 [DOI] [PubMed] [Google Scholar]
- 20. Zakharov S. D., and Cramer W. A. (2002) Colicin crystal structures: pathways and mechanisms for colicin insertion into membranes. Biochim. Biophys. Acta 1565, 333–346 10.1016/S0005-2736(02)00579-5 [DOI] [PubMed] [Google Scholar]
- 21. Kienker P. K., Qiu X., Slatin S. L., Finkelstein A., and Jakes K. S. (1997) Transmembrane insertion of the colicin Ia hydrophobic hairpin. J. Membr. Biol. 157, 27–37 10.1007/s002329900213 [DOI] [PubMed] [Google Scholar]
- 22. Wang J., and London E. (2009) The membrane topography of the diphtheria toxin T domain linked to the a chain reveals a transient transmembrane hairpin and potential translocation mechanisms. Biochemistry 48, 10446–10456 10.1021/bi9014665 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Silverman J. A., Mindell J. A., Finkelstein A., Shen W. H., and Collier R. J. (1994) Mutational analysis of the helical hairpin region of diphtheria toxin transmembrane domain. J. Biol. Chem. 269, 22524–22532 [PubMed] [Google Scholar]
- 24. Pérez-Morga D., Vanhollebeke B., Paturiaux-Hanocq F., Nolan D. P., Lins L., Homblé F., Vanhamme L., Tebabi P., Pays A., Poelvoorde P., Jacquet A., Brasseur R., and Pays E. (2005) Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309, 469–472 10.1126/science.1114566 [DOI] [PubMed] [Google Scholar]
- 25. Verdi J., Schaub C., Thomson R., and Raper J. (2020) All you ever wanted to know about APOL1 and TLFs and did not dare ask. Methods Mol. Biol. 2116, 463–483 10.1007/978-1-0716-0294-2_28 [DOI] [PubMed] [Google Scholar]
- 26. Mindell J. A., Silverman J. A., Collier R. J., and Finkelstein A. (1994) Structure-function relationships in diphtheria toxin channels: III. Residues which affect the cis pH dependence of channel conductance. J. Membr. Biol. 137, 45–57 10.1007/BF00234997 [DOI] [PubMed] [Google Scholar]
- 27. Kageruka P., Mangus E., Bajyana Songa E., Nantulya V., Jochems M., Hamers R., and Mortelmans J. (1991) Infectivity of Trypanosoma (Trypanozoon) brucei gambiense for baboons (Papio hamadryas, Papio papio). Ann. Soc. Belg. Med. Trop. 71, 39–46 [PubMed] [Google Scholar]
- 28. Cooper A., Capewell P., Clucas C., Veitch N., Weir W., Thomson R., Raper J., and MacLeod A. (2016) A primate APOL1 variant that kills Trypanosoma brucei gambiense. PLoS Negl. Trop. Dis. 10, e0004903 10.1371/journal.pntd.0004903 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Parker M. W., Pattus F., Tucker A. D., and Tsernoglou D. (1989) Structure of the membrane-pore-forming fragment of colicin A. Nature 337, 93–96 10.1038/337093a0 [DOI] [PubMed] [Google Scholar]
- 30. Huynh P. D., Cui C., Zhan H., Oh K. J., Collier R. J., and Finkelstein A. (1997) Probing the structure of the diphtheria toxin channel: reactivity in planar lipid bilayer membranes of cysteine-substituted mutant channels with methanethiosulfonate derivatives. J. Gen. Physiol. 110, 229–242 10.1085/jgp.110.3.229 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Kaul P., Silverman J., Shen W. H., Blanke S. R., Huynh P. D., Finkelstein A., and Collier R. J. (1996) Roles of Glu 349 and Asp 352 in membrane insertion and translocation by diphtheria toxin. Protein Sci. 5, 687–692 10.1002/pro.5560050413 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Martinez M. C., Lazdunski C., and Pattus F. (1983) Isolation, molecular and functional properties of the C-terminal domain of colicin A. EMBO J. 2, 1501–1507 10.1002/j.1460-2075.1983.tb01614.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Lecordier L., Vanhollebeke B., Poelvoorde P., Tebabi P., Paturiaux-Hanocq F., Andris F., Lins L., and Pays E. (2009) C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. PLoS Pathog. 5, e1000685 10.1371/journal.ppat.1000685 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Sobko A. A., Kotova E. A., Antonenko Y. N., Zakharov S. D., and Cramer W. A. (2004) Effect of lipids with different spontaneous curvature on the channel activity of colicin E1: evidence in favor of a toroidal pore. FEBS Lett. 576, 205–210 10.1016/j.febslet.2004.09.016 [DOI] [PubMed] [Google Scholar]
- 35. (2009) Pore-loop channels. In Encyclopedia of Neuroscience (Binder M.D., Hirokawa N., and Windhorst U., eds) p. 3183, Springer, Berlin [Google Scholar]
- 36. Vanwalleghem G., Fontaine F., Lecordier L., Tebabi P., Klewe K., Nolan D. P., Yamaryo-Botté Y., Botté C., Kremer A., Burkard G. S., Rassow J., Roditi I., Pérez-Morga D., and Pays E. (2015) Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1. Nat. Commun. 6, 8078 10.1038/ncomms9078 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Lannon H., Shah S. S., Dias L., Blackler D., Alper S. L., Pollak M. R., and Friedman D. J. (2019) Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background. Kidney Int. 96, 1303–1307 10.1016/j.kint.2019.07.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Hirumi H., and Hirumi K. (1989) Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J Parasitol 75, 985–989 10.2307/3282883 [DOI] [PubMed] [Google Scholar]
- 39. Kagawa Y., and Racker E. (1971) Partial resolution of the enzymes catalyzing oxidative phosphorylation: XXV. Reconstitution of vesicles catalyzing 32Pi-adenosine triphosphate exchange. J. Biol. Chem. 246, 5477–5487 [Google Scholar]
- 40. Qiu X. Q., Jakes K. S., Kienker P. K., Finkelstein A., and Slatin S. L. (1996) Major transmembrane movement associated with colicin Ia channel gating. J. Gen. Physiol. 107, 313–328 10.1085/jgp.107.3.313 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Robinson R. A., and Stokes R. H. (1965) Electrolyte Solutions, 2nd (revised) Ed., pp. 223–252, Butterworths, London [Google Scholar]
- 42. Omasits U., Ahrens C. H., Müller S., and Wollscheid B. (2014) Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics 30, 884–886 10.1093/bioinformatics/btt607 [DOI] [PubMed] [Google Scholar]
- 43. DeLano W. L. (2012) The PyMOL Molecular Graphics System, version 1.5.0.1, Schroedinger, LLC, New York [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are contained in the article or in the supporting information.